Literature DB >> 21534339

Abdominal obesity is an independent risk factor for increased carotid intima- media thickness in obese children.

Bülent Hacihamdioğlu1, Vedat Okutan, Yilmaz Yozgat, Düzgün Yildirim, Murat Kocaoğlu, Mustafa Koray Lenk, Okan Ozcan.   

Abstract

We aimed in this study to investigate carotid intima-media thickness (IMT) in obese children and evaluate the relationship of IMT to various cardiovascular risk factors. One-hundred four obese children (9.3 +/- 2.5 years) and 30 healthy age-matched control subjects were enrolled in the study. All children were assessed for fasting levels of glucose, insulin, lipid profile, skinfold thickness (SFT), waist circumference (WC), and blood pressure (BP). Insulin resistance was estimated by the homeostasis model assessment (HOMA) index. Carotid IMT measurements and non-alcoholic fatty liver disease (NAFLD) were diagnosed with ultrasonographic findings. IMT was significantly higher in obese children compared to controls (0.49 +/- 0.05 vs. 0.40 +/- 0.02 mm, p < 0.001). Significant positive correlations were found between increased carotid IMT and body fat percentage (BFP), body mass index (BMI), age, height, systolic BP, WC, SFT, triglyceride and insulin levels, and insulin resistance index. In a linear logistic regression analysis, the only parameter affecting the increase in carotid IMT was WC (beta: 0.589, p < 0.001). Furthermore, IMT was increased significantly in obese children with NAFLD when compared to obese children without NAFLD (0.54 +/- 0.04 vs. 0.48 +/- 0.05 mm, p < 0.001). Children with abdominal obesity are at increased risk for atherosclerosis, and WC can be used to determine the atherosclerosis risk in obese children.

Entities:  

Mesh:

Year:  2011        PMID: 21534339

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  13 in total

Review 1.  Nonalcoholic fatty liver disease and cardiovascular disease.

Authors:  Hong Liu; Hong-Yun Lu
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 2.  Nonalcoholic fatty liver disease: implications for cardiovascular risk.

Authors:  Amreen Dinani; Arun Sanyal
Journal:  Cardiovasc Endocrinol       Date:  2017-05-17

3.  Childhood obesity: a review of increased risk for physical and psychological comorbidities.

Authors:  Elizabeth R Pulgarón
Journal:  Clin Ther       Date:  2013-01       Impact factor: 3.393

Review 4.  Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.

Authors:  Silvia Fargion; Marianna Porzio; Anna Ludovica Fracanzani
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

5.  The preliminary effects of a primary care-based randomized treatment trial with overweight and obese young children and their parents.

Authors:  Leigh Small; Darya Bonds-McClain; Bernadette Melnyk; Linda Vaughan; Alex M Gannon
Journal:  J Pediatr Health Care       Date:  2013-03-17       Impact factor: 1.812

6.  Obesity and air pollution: global risk factors for pediatric non-alcoholic fatty liver disease.

Authors:  Roya Kelishadi; Parinaz Poursafa
Journal:  Hepat Mon       Date:  2011-10       Impact factor: 0.660

7.  The Association between Carotid Atherosclerosis and Glucose.

Authors:  Bo Kyung Koo
Journal:  Diabetes Metab J       Date:  2011-10-31       Impact factor: 5.376

8.  Arterial structure and function in ambulatory adolescents with cerebral palsy are not different from healthy controls.

Authors:  Audra A Martin; Lisa M Cotie; Brian W Timmons; Jan Willem Gorter; Maureen J Macdonald
Journal:  Int J Pediatr       Date:  2012-06-10

Review 9.  Systematic review on the association of abdominal obesity in children and adolescents with cardio-metabolic risk factors.

Authors:  Roya Kelishadi; Parisa Mirmoghtadaee; Hananeh Najafi; Mojtaba Keikha
Journal:  J Res Med Sci       Date:  2015-03       Impact factor: 1.852

10.  A study on carotid artery intima-media thickness and metabolic risk factors in overweight and obese Indian children.

Authors:  Vignatha Sajja; Dhivyalakshmi Jeevarathnam; Saji James; Jebaraj Rathinasamy
Journal:  Diabetol Int       Date:  2019-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.